Aprea Therapeutics
APRE
APRE
18 hedge funds and large institutions have $3.77M invested in Aprea Therapeutics in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 12 reducing their positions, and 13 closing their positions.
Holders
18
Holders Change
-7
Holders Change %
-28%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
12
Closed
13
Calls
$615K
Puts
–
Net Calls
+$615K
Net Calls Change
+$433K
Top Buyers
Top Sellers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$68.8K |
2 |
2
Morgan Stanley
New York
|
$64.6K |
3 |
3
BlackRock
New York
|
$41K |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$7K |
5 |
![]()
5
Group One Trading
Chicago,
Illinois
|
$9.61K |